FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126000729> ?p ?o ?g. }

• W2126000729 endingPage "208" @default.
• W2126000729 startingPage "201" @default.
• W2126000729 abstract "We sought to examine the use and impact of standard medical therapies in patients with end-stage renal disease (ESRD) faced with an acute myocardial infarction (AMI).The poor prognosis of patients in this high-risk population has become increasingly well recognized.Using the ESRD database and the Cooperative Cardiovascular Project (CCP) database, we identified AMI patients who were receiving either peritoneal dialysis or hemodialysis before admission. The early administration of aspirin and beta-blockers was compared between ESRD and non-ESRD patients and the effect of these therapies on 30-day mortality was evaluated with logistic regression models.The cohort consisted of 145,740 patients without ESRD and 1,025 patients with ESRD. Aspirin (67.0% vs. 82.4%, p < 0.001), beta-blockers (43.2% vs. 50.8%, p < 0.001), and angiotensin-converting enzyme (ACE) inhibitors (38.5% vs. 60.3%, p < 0.001) were less likely to be administered to ESRD patients than to non-ESRD patients. The benefit of these therapies on 30-day mortality was similar among ESRD patients (aspirin: relative risk [RR] 0.64; 95% confidence interval [CI] 0.50 to 0.80; beta-blocker: RR 0.78; 95% CI 0.60 to 0.99; ACE inhibitor: RR 0.58; 95% CI 0.42 to 0.77) and non-ESRD patients (aspirin: RR 0.57; 95% CI 0.55 to 0.58; beta-blocker: RR 0.70; 95% CI 0.68 to 0.72; ACE inhibitor: RR 0.64; 95% CI 0.63 to 0.66).End-stage renal disease patients are far less likely than non-ESRD patients to be treated with aspirin, beta-blockers, and ACE inhibitors during an admission for AMI. The lower rates of usage for these medications, particularly aspirin, may contribute to the increased 30-day mortality. These findings demonstrate a marked opportunity to improve care in this population." @default.
• W2126000729 created "2016-06-24" @default.
• W2126000729 creator A5013714927 @default.
• W2126000729 creator A5020751544 @default.
• W2126000729 creator A5088028306 @default.
• W2126000729 date "2003-07-01" @default.
• W2126000729 modified "2023-10-17" @default.
• W2126000729 title "Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction" @default.
• W2126000729 cites W1596397105 @default.
• W2126000729 cites W186946926 @default.
• W2126000729 cites W1968295100 @default.
• W2126000729 cites W1968668632 @default.
• W2126000729 cites W1984595407 @default.
• W2126000729 cites W1992332433 @default.
• W2126000729 cites W2035587517 @default.
• W2126000729 cites W2041427341 @default.
• W2126000729 cites W2060451901 @default.
• W2126000729 cites W2061137783 @default.
• W2126000729 cites W2099882339 @default.
• W2126000729 cites W2112947357 @default.
• W2126000729 cites W2126015020 @default.
• W2126000729 cites W2150157334 @default.
• W2126000729 cites W2157825442 @default.
• W2126000729 cites W2972196084 @default.
• W2126000729 cites W4239943088 @default.
• W2126000729 cites W4252241269 @default.
• W2126000729 doi "https://doi.org/10.1016/s0735-1097(03)00572-2" @default.
• W2126000729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12875751" @default.
• W2126000729 hasPublicationYear "2003" @default.
• W2126000729 type Work @default.
• W2126000729 sameAs 2126000729 @default.
• W2126000729 citedByCount "281" @default.
• W2126000729 countsByYear W21260007292012 @default.
• W2126000729 countsByYear W21260007292013 @default.
• W2126000729 countsByYear W21260007292014 @default.
• W2126000729 countsByYear W21260007292015 @default.
• W2126000729 countsByYear W21260007292016 @default.
• W2126000729 countsByYear W21260007292017 @default.
• W2126000729 countsByYear W21260007292018 @default.
• W2126000729 countsByYear W21260007292019 @default.
• W2126000729 countsByYear W21260007292020 @default.
• W2126000729 countsByYear W21260007292021 @default.
• W2126000729 countsByYear W21260007292022 @default.
• W2126000729 countsByYear W21260007292023 @default.
• W2126000729 crossrefType "journal-article" @default.
• W2126000729 hasAuthorship W2126000729A5013714927 @default.
• W2126000729 hasAuthorship W2126000729A5020751544 @default.
• W2126000729 hasAuthorship W2126000729A5088028306 @default.
• W2126000729 hasBestOaLocation W21260007291 @default.
• W2126000729 hasConcept C126322002 @default.
• W2126000729 hasConcept C164705383 @default.
• W2126000729 hasConcept C27016395 @default.
• W2126000729 hasConcept C2777628954 @default.
• W2126000729 hasConcept C2778063415 @default.
• W2126000729 hasConcept C2778653478 @default.
• W2126000729 hasConcept C2779056158 @default.
• W2126000729 hasConcept C2779611605 @default.
• W2126000729 hasConcept C2779978075 @default.
• W2126000729 hasConcept C2908647359 @default.
• W2126000729 hasConcept C3019040382 @default.
• W2126000729 hasConcept C44249647 @default.
• W2126000729 hasConcept C500558357 @default.
• W2126000729 hasConcept C71924100 @default.
• W2126000729 hasConcept C82789193 @default.
• W2126000729 hasConcept C84393581 @default.
• W2126000729 hasConcept C99454951 @default.
• W2126000729 hasConceptScore W2126000729C126322002 @default.
• W2126000729 hasConceptScore W2126000729C164705383 @default.
• W2126000729 hasConceptScore W2126000729C27016395 @default.
• W2126000729 hasConceptScore W2126000729C2777628954 @default.
• W2126000729 hasConceptScore W2126000729C2778063415 @default.
• W2126000729 hasConceptScore W2126000729C2778653478 @default.
• W2126000729 hasConceptScore W2126000729C2779056158 @default.
• W2126000729 hasConceptScore W2126000729C2779611605 @default.
• W2126000729 hasConceptScore W2126000729C2779978075 @default.
• W2126000729 hasConceptScore W2126000729C2908647359 @default.
• W2126000729 hasConceptScore W2126000729C3019040382 @default.
• W2126000729 hasConceptScore W2126000729C44249647 @default.
• W2126000729 hasConceptScore W2126000729C500558357 @default.
• W2126000729 hasConceptScore W2126000729C71924100 @default.
• W2126000729 hasConceptScore W2126000729C82789193 @default.
• W2126000729 hasConceptScore W2126000729C84393581 @default.
• W2126000729 hasConceptScore W2126000729C99454951 @default.
• W2126000729 hasIssue "2" @default.
• W2126000729 hasLocation W21260007291 @default.
• W2126000729 hasLocation W21260007292 @default.
• W2126000729 hasOpenAccess W2126000729 @default.
• W2126000729 hasPrimaryLocation W21260007291 @default.
• W2126000729 hasRelatedWork W1997518038 @default.
• W2126000729 hasRelatedWork W1998672586 @default.
• W2126000729 hasRelatedWork W2013228045 @default.
• W2126000729 hasRelatedWork W2015679682 @default.
• W2126000729 hasRelatedWork W2160709476 @default.
• W2126000729 hasRelatedWork W2186768350 @default.
• W2126000729 hasRelatedWork W2398445761 @default.
• W2126000729 hasRelatedWork W2415614104 @default.
• W2126000729 hasRelatedWork W2790461664 @default.
• W2126000729 hasRelatedWork W3007801526 @default.

• next